For research use only. Not for therapeutic Use.
Nadoxolol(CAT: I033005) is a potent, non-selective beta-adrenergic receptor antagonist with intrinsic sympathomimetic activity (ISA). It is widely utilized in cardiovascular research, particularly in studies focused on hypertension, arrhythmias, and myocardial ischemia. By modulating beta-adrenergic signaling, Nadoxolol aids in understanding the physiological and pharmacological responses of the cardiovascular system. Its high purity and stability ensure reliable experimental outcomes, making it an essential tool for researchers exploring beta-blocker mechanisms, adrenergic pathways, and potential therapeutic applications in cardiovascular disorders.
Catalog Number | I033005 |
CAS Number | 54063-51-3 |
Synonyms | Nadoxolol; Nadoxololum; LL 1530; LL-1530; LL1530; |
Molecular Formula | C14H16N2O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | N',3-dihydroxy-4-naphthalen-1-yloxybutanimidamide |
InChI | InChI=1S/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16) |
InChIKey | UPZVYDSBLFNMLK-UHFFFAOYSA-N |
SMILES | N/C(CC(O)COC1=C2C=CC=CC2=CC=C1)=NO |